Assuming PRED-462 corresponds to a graduate-level course in a field like Policy, Research, Evaluation, or Education (e.g., ), this course likely aims to equip students with advanced skills in designing, implementing, and evaluating research or policy interventions. The target audience may include graduate students or professionals seeking expertise in evidence-based decision-making, program evaluation, or academic research.
Common evaluation tasks include:
Based on academic course catalogs, is a course titled "Applied Research in Math and Science Education" PRED-462
| Year | Milestone | |------|-----------| | | Hit identification via high‑throughput screening of ~2 M compounds. | | 2023 | Lead optimization; PRED‑462 selected for superior potency and ADME profile. | | 2024 | IND‑enabling toxicology completed; filing of a provisional patent. | | 2025 | First‑in‑human (FIH) Phase I trial initiated in healthy volunteers (single‑ascending dose). | | 2026 (Projected) | Expansion into Phase Ib/IIa oncology trial in estrogen‑receptor‑positive (ER⁺) breast cancer patients. | Assuming PRED-462 corresponds to a graduate-level course in
These early data suggest a , but human safety will ultimately be defined by the ongoing Phase I trial. | | 2023 | Lead optimization; PRED‑462 selected